NCOA3 and neoplasm: Since inhibitors of AIB1 are currently being explored as a possibly future breast cancer treatment [26], we find it important to further investigate the function of AIB1 in relation to different tumor characteristics and treatment settings, and we think this study contributes to that knowledge.